June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
The Role of Chlamydia in HLA-B27 Acute Anterior Uveitis and Seronegative Arthritis
Author Affiliations & Notes
  • Shahriar Amjadi
    School of Medical Science, University of New South Wales, Turramurra, Sydney, NSW, Australia
    Department of Ophthalmology, Lyell McEwin Hospital, Adelaide, SA, Australia
  • Peter Robertson
    South Eastern Area Laboratory Services, Prince of Wales Hospital, Sydney, NSW, Australia
  • Peter J McCluskey
    Save Sight Institute, University of Sydney, Sydney, NSW, Australia
  • Denis Wakefield
    School of Medical Science, University of New South Wales, Turramurra, Sydney, NSW, Australia
  • Footnotes
    Commercial Relationships Shahriar Amjadi, None; Peter Robertson, None; Peter McCluskey, None; Denis Wakefield, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 1847. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Shahriar Amjadi, Peter Robertson, Peter J McCluskey, Denis Wakefield; The Role of Chlamydia in HLA-B27 Acute Anterior Uveitis and Seronegative Arthritis. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):1847.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: This study aimed to determine the prevalence of positive serology to Chlamydia in patients with Acute Anterior Uveitis (AAU) and Seronegative Arthritis (SNA) as cross-reactivity between self-peptides and bacterial antigens such as Chlamydia may be a pathogenic mechanism for HLA-B27 disease.

Methods: Serum was obtained from patients with a past history of AAU and/or SNA (n=188). The patients were further stratified as follows: All patients with AAU (n=176), all HLA-B27 positive patients (n=116), HLA-B27 positive patients with AAU (n=102), HLA-B27 positive patients with SNA (n=49), HLA-B27 positive patients with both AAU and SNA (n=37), HLA-B27 positive patients with AAU but no SNA (n=65), HLA-B27 positive patients with SNA but no AAU (n=12) and HLA-B27-negative patients (all AAU) (n=72). Healthy age and sex-matched HLA-B27 negative controls were recruited (n=13) as well as controls from MEDAC GmbH (Hamburg, Germany) (n=416). Serology was undertaken using a commercially available recombinant ELISA kit that detects IgG, IgM and IgA directed against a Chlamydia-specific lipopolysaccharide (MEDAC GmbH). Statistical analysis was performed using a Fisher exact test.

Results: The prevalence of IgG positivity to Chlamydia in patients who were HLA-B27 positive with both AAU and SNA (48.65%) was significantly higher compared to healthy controls (15.38%) (p<0.05). In comparison to the healthy controls recruited by MEDAC, the following groups had significantly higher proportions of positive IgA and IgM titers compared to controls from MEDAC (13.0%, 3.0%, respectively): all HLA-B27 positive patients (35.1%, 11.7%), HLAB27 positive patients with AAU (32.4%, 10.8%), HLA-B27 positive patients with SNA (32.7%, 10.2%), HLA-B27 positive patients with both AAU and SNA (35.1%, 10.8%) (p<0.05).

Conclusions: Patients with HLA-B27 AAU and SNA disease have evidence of exposure to Chlamydia. HLA-B27 patients with both AAU and SNA have a higher rate of seropositivity compared to controls.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×